Results 211 to 220 of about 19,701 (225)

The efficacy and safety of DPP4 inhibitors in patients with type 1 diabetes: A systematic review and meta-analysis

Diabetes Research and Clinical Practice, 2016
Linqi Chen
exaly  

DPP4

2018
openaire   +1 more source

Soluble DPP4 originates in part from bone marrow cells and not from the kidney

Peptides, 2014
Kerstin Amann, Stephan von Horsten, Zhendi Wang   +2 more
exaly  

FosB recruits KAT5 to potentiate the growth and metastasis of papillary thyroid cancer in a DPP4-dependent manner

Life Sciences, 2020
Xinguang Qiu
exaly  

Teneligliptin – The newest DPP4 inhibitor

International Journal of Pharma and Bio Sciences, 2017
DR. MAYURESH KIRAN, DR. H.B. CHAN DALIA, DR. PRAMILA YADAV   +2 more
openaire   +1 more source

Reduced DPP4 activity improves insulin signaling in primary human adipocytes

Biochemical and Biophysical Research Communications, 2016
Jürgen Eckel, Henrike Sell
exaly  

Dipeptidyl peptidase-4 (DPP4) inhibition in COVID-19

Acta Diabetologica, 2020
Massimo Galli, Antonio di Sabatino, Paolo Fiorina   +2 more
exaly  

DPP4- oder SGLT2-Hemmer ?

MMW - Fortschritte der Medizin, 2018
openaire   +1 more source

Unravelling the immunological roles of dipeptidyl peptidase 4 (DPP4) activity and/or structure homologue (DASH) proteins

Clinical and Experimental Immunology, 2016
Stephan von Horsten, Christian Klemann, Leona Wagner   +2 more
exaly  

DPP4-2018.pdf

2018
openaire   +1 more source